Medicover AB Statistics

Total Valuation

Medicover AB has a market cap or net worth of 3.81 billion. The enterprise value is 5.14 billion.

Market Cap	3.81B
Enterprise Value	5.14B

Important Dates

The next estimated earnings date is Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	74.35M
Shares Outstanding	n/a
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	50.83M

Valuation Ratios

The trailing PE ratio is 115.23 and the forward PE ratio is 46.18.

PE Ratio	115.23
Forward PE	46.18
PS Ratio	1.62
PB Ratio	6.93
P/TBV Ratio	n/a
P/FCF Ratio	23.78
P/OCF Ratio	13.02
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.30, with an EV/FCF ratio of 32.04.

EV / Earnings	155.29
EV / Sales	2.07
EV / EBITDA	16.30
EV / EBIT	49.79
EV / FCF	32.04

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 2.45.

Current Ratio	0.85
Quick Ratio	0.73
Debt / Equity	2.45
Debt / EBITDA	4.52
Debt / FCF	8.40
Interest Coverage	1.46

Financial Efficiency

Return on equity (ROE) is 5.12% and return on invested capital (ROIC) is 3.35%.

Return on Equity (ROE)	5.12%
Return on Assets (ROA)	2.70%
Return on Invested Capital (ROIC)	3.35%
Return on Capital Employed (ROCE)	5.60%
Revenue Per Employee	49,928
Profits Per Employee	704
Employee Count	47,256
Asset Turnover	1.04
Inventory Turnover	27.47

Taxes

In the past 12 months, Medicover AB has paid 11.46 million in taxes.

Income Tax	11.46M
Effective Tax Rate	28.27%

Stock Price Statistics

The stock price has increased by +8.96% in the last 52 weeks. The beta is 1.56, so Medicover AB's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	+8.96%
50-Day Moving Average	20.81
200-Day Moving Average	17.50
Relative Strength Index (RSI)	97.77
Average Volume (20 Days)	160

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicover AB had revenue of 2.35 billion and earned 33.07 million in profits. Earnings per share was 0.22.

Revenue	2.35B
Gross Profit	514.92M
Operating Income	97.49M
Pretax Income	40.53M
Net Income	33.07M
EBITDA	203.42M
EBIT	97.49M
Earnings Per Share (EPS)	0.22

Full Income Statement

Balance Sheet

The company has 116.73 million in cash and 1.35 billion in debt, giving a net cash position of -1.23 billion.

Cash & Cash Equivalents	116.73M
Total Debt	1.35B
Net Cash	-1.23B
Net Cash Per Share	n/a
Equity (Book Value)	550.26M
Book Value Per Share	3.51
Working Capital	-90.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 292.80 million and capital expenditures -132.51 million, giving a free cash flow of 160.29 million.

Operating Cash Flow	292.80M
Capital Expenditures	-132.51M
Free Cash Flow	160.29M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 21.94%, with operating and profit margins of 4.15% and 1.41%.

Gross Margin	21.94%
Operating Margin	4.15%
Pretax Margin	1.73%
Profit Margin	1.41%
EBITDA Margin	8.67%
EBIT Margin	4.15%
FCF Margin	6.83%

Dividends & Yields

This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 0.85%.

Dividend Per Share	0.17
Dividend Yield	0.85%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	58.82%
Buyback Yield	-0.35%
Shareholder Yield	0.51%
Earnings Yield	0.87%
FCF Yield	4.21%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medicover AB has an Altman Z-Score of 2.04 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.04
Piotroski F-Score	7